Research in colon and rectal cancer, with an emphasis on surgical progress

Diseases of the Colon and Rectum

Volumn 42, Issue 11, 1999, Pages 1369-1380

  Ky, Alex J ^a   Sung, Max W ^a   Milsom, Jeffrey W ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHYNYLURACIL; ANTINEOPLASTIC AGENT; ARYLBUTYRIC ACID DERIVATIVE; CAPECITABINE; EDRECOLOMAB; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; INTERLEUKIN 12; INTERLEUKIN 2; IRINOTECAN; LEVAMISOLE; OXALIPLATIN; RALTITREXED; TEGAFUR; URACIL;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RESEARCH; CANCER SURGERY; COLON CARCINOMA; GENE THERAPY; HISTORY OF MEDICINE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL EDUCATION; MEDICAL TECHNOLOGY; ORAL DRUG ADMINISTRATION; RECTUM CARCINOMA; REVIEW; SUICIDE GENE; SURGICAL TECHNIQUE; TUMOR SUPPRESSOR GENE;

EID: 0032733901     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02235032     Document Type: Review

References (65)

1. Troidl H, Spitzer WO, Mulder DS, et al. eds. Principles and practice of research: strategies for surgical investigators. New York: Springer, 1991.
2. Popper K. Conjectures and refutations. the growth of scientific knowledge. 4th ed. London: Routledge & Kegan Paul, 1972:129.
3. Stamp J. Quoted by Dunea G. Swallowing the golden ball. BMJ 1983;286:1962-3.
4. Yates F, Mather K. Ronald Aylmer Fisher 1890-1962. Biographical Memoirs of Fellows of the Royal Society 1963;9:91-129.
5. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948;2:769-82.
6. Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967;201:943-5.
7. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
8. Kronborg O, Fenger C, Olsen O, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467-71.
9. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348: 1472-7.
10. Banov L. Hippocratic proctology. South Med J 1967;60: 667-70.
11. Turell R. Diseases of the colon and rectum. Philadelphia: WB Saunders, 1969.
12. Tuttle JP. A treatise on diseases of the anus, rectum, and pelvic colon. New York: D Appleton, 1907.
13. Overholt BF. Flexible fiberoptic sigmoidoscopy: technique and preliminary results. Cancer 1971;28:123-6.
14. Wolff WI, Shinya H. Colonofiberoscopy. JAMA 1971; 217:1509-12.
15. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
16. Cannon W. The movements of the stomach studied by means of the roentgen rays. Am J Physiol 1898;1: 359-82.
17. Fischer AW. A new roentgenologic method for examination of the large intestine: a combination of the contrast material enema and insufflation of air [in German]. Klin Wochenschr 1923;2:1595-8.
18. Welin S, Youker J, Spratt JS Jr. The rates and patterns of growth of 375 tumors of the large intestine and rectum observed serially by double contrast enema study (Malmo Technique). AJR 1963;90:673-87.
19. Ruo L, Guillem JG. Major 20th-century advancements in the management of rectal cancer. Dis Colon Rectum 1999;42:563-78.
20. Royster AP, Fenlon HM, Clarke PD, et al. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc 1997;45: 451-5.
21. Lumboldt W, Debatin JF. Virtual endoscopie colonography based on 3D MRI. Abdom Imaging 1998;23: 568-72.
22. Valk PE, Abella-Columna E, Haseman MK, et al. Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503-11.
23. ®-Tc), a totally human monoclonal antibody: patient management benefit from a Phase III multicenter study. Dis Colon Rectum 1998;41:953-62.
24. Scheithauer W, Rosen H, Kornek G, Sebesta C, Depisch D. Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993; 306:752-5.
25. The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
26. Cunningham D, Pyrhonen S, James RD, et al. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352: 1413-8.
27. Saltz LB, Locker PK, Pirotta N, et al. Weekly irinotecan (CPT-11), leucovorin (LV), and fluorouracil (FU) is superior to daily x5 LV/FU in patients with previous untreated metastatic colorectal cancer (CRC) [abstract]. Proc Am Soc Clin Oncol 1999;20:898A.
28. DeGramont A, Figer A, Seymour M, et al. A randomized trial of leucovorin and 5-fluorouracil with or without oxaliplatin in advanced colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1998;19:985A.
29. Carmichael J, Popiela T, Radstone D, Falk S, et al. Randomized comparative study of ORZEL (oral uracil/ tegafur (UFT) plus leucovorin) versus parenteral 5-flourouracil plus leucovorin in patients with metastatic colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1999;20:1015A.
30. Cox JV, Pzadur R, Thibault A. A phase III trial of XE-LODA (Capecitabine) in previously untreated advanced/metastatic colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1999;20:1069A.
31. Brunet R, Fonck M, Smith D, et al. Management of metastatic colorectal cancer (MCRC): results of a strategy with first line Tomudex chemotherapy [abstract]. Proc Am Soc Clin Oncol 1999;20:1069A.
32. Huang Y, Waxman S. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate. Clin Cancer Res 1998;4:2503-9.
33. Sung MW, Waxman S. Chemodifferentiation therapy with fluorouracil and phenylbutyrate in advanced colorectal cancer: a phase I trial [abstract]. Proc Am Assoc Cancer Res 1999;40:2245A.
34. Kenemy N, Conti JA, Cohen A., et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288-95.
35. Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of Stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
36. O'Connell MJ, Laurie JA, Shepherd L, et al. A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for high-risk colon cancer: a collaborative trial of the North Central Cancer Treatment Group and the National Cancer Institute of Canada Clinical Trials Group. Proc Am Soc Clin Oncol 1996;15:209.
37. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al., and the German Cancer Aid 17-1A Study Group. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;33:1177-83.
38. Gastroinestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-72.
39. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
40. O'Connell MJ, Martenson JA, Weiand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation after curative surgery. N Engl J Med 1994;331:502-7.
41. Chen SH, Chen XH, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A 1995;92:2577-81.
42. Sung MW, Yeh HC, Mandeli JP, et al. Intratumoral suicide gene therapy in colorectal cancer metastatic to the liver: a phase I trial of recombinant adenoviral vector expressing the Herpes Simplex Virus thymidine kinase followed by intravenous ganciclovir. Proc Am Assoc Cancer Res 1999;40:2103A.
43. Chen SH, Kosai K, Xu B, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 1996;56:3758-62.
44. Caruso M, Pham-Nguyen K, Kwong YL, et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 1996;93: 11302-6.
45. Anderson SC, Johnson DE, Harris MP, et al. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. Clin Cancer Res 1998;4:1649-59.
46. Rutkow IM. Surgery. An Illustrated History. Saint Louis: Mosby-Year Book, 1993.
47. US Department of Health, and Human Services. Closing in on cancer: solving a 5000-year-old mystery. NIH Publication no. 87-2955, 1987.
48. Lockhart-Mummery P. Resection of the rectum for cancer. Lancet 1920;1:20-1.
49. Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;2:1812-3.
50. Rankin FW. The technique of anterior resection of the rectosigmoid. Surg Gynecol Obstet 1928;46:537-46.
51. Dixon CF. Anterior resection for malignant lesions of the upper part of the rectum and lower part of the sigmoid. Ann Surg 1948;128:425-42.
52. Heald RJ. Towards fewer colostomies - the impact of circular stapling devices on the surgery of rectal cancer in a district hospital. Br J Surg 1980;60:198-200.
53. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma - experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995; 81(Suppl):60-4.
54. Reybard TF. Memoire sur une Tumeur Cancereuse affectant l's iliaque du colon; ablation de la tumeur et de l'intestin; Reunion directe et immediate de deux bouts de cet organe; guerison. Bull Acad Royale de Med 1943-44;9:1031.
55. Paul FT. Colectomy. BMJ 1895;1:1136.
56. von Mikulicz J. Chirurgische erjahrun uber das Darm-carcinom. Arch Klin Chir Berl 1903;69:28.
57. Bloch OT. Om extra-abdominal behandlung af cancer intestinalis (rectum derfra undtaget) med en frem stilling af do for denne sugdom foretague operationer og deres resultater. Nord Med Arh 1982;24:1.
58. Black WA, Waugh JM. The intramural extension of carcinoma of the descending colon, sigmoid, and rectosigmoid: a pathologic study. Surg Gynecol Obstet 1948;87:457-64.
59. Grinnell RS. Results of ligation of inferior mesenteric artery at the aorta in resections of carcinoma of the descending and sigmoid colon and rectum. Surg Gynecol Obstet 1965;120:1031-6.
60. Grinnell RS, Hiatt RB. Ligation of the inferior mesenteric artery at the aorta in resections for carcinoma of the sigmoid and rectum. Surg Gynecol Obstet 1952;94: 526-9.
61. Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420-7.
62. Parc YR, Radice Em, Dozois RR. Surgery for ulcerative colitis: Historical perspective. Dis Colon Rectum 1999; 42:299-306.
63. Cosimelli M, Mannella E, Giannarelli D, et al. Nerve-sparing surgery in 302 resectable rectosigmoid cancer patients: genitourinary morbidity and 10-year survival. Dis Colon Rectum 1994;37(Suppl):S42-6.
64. Havenga K, Enker WE, McDermott K, et al. Male and female sexual function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996;182:495-502.
65. Milsom JW, Bohm B, Hammerhofer KA, et al. A prospective randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg 1998;187: 46-54.